Suchergebnisse - "Weaver, James"

PubPharm (19)

1

Scientific and Regulatory Policy Committee Points-to-consider Paper* : Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part I. Biotherapeutics

enthalten in: Toxicologic pathology | 2015

von Frazier, K. | Engelhardt, J. | Fant, P. | +8

2

Scientific and Regulatory Policy Committee Points-to-consider Paper* : Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part 2. Antisense Oligonucleotides

enthalten in: Toxicologic pathology | 2015

von Engelhardt, J. | Fant, P. | Guionaud, S. | +8

3

Scientific and Regulatory Policy Committee Points-to-consider Paper: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part 2. Antisense Oligonucleotides

enthalten in: Toxicologic pathology | 2015

von Engelhardt, J. | Fant, P. | Guionaud, S. | +7

4

Scientific and Regulatory Policy Committee Points-to-consider Paper: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part I. Biotherapeutics

enthalten in: Toxicologic pathology | 2015

von Frazier, K. | Engelhardt, J. | Fant, P. | +7

5

The role of eNOS phosphorylation in causing drug-induced vascular injury

enthalten in: Toxicologic pathology | 2014

von Tobin, G. | Zhang, J. | Goodwin, D. | +9

6

Nonclinical safety biomarkers of drug-induced vascular injury : current status and blueprint for the future

enthalten in: Toxicologic pathology | 2014

von Mikaelian, I. | Cameron, M. | Dalmas, D. | +12

7

Nonclinical Safety Biomarkers of Drug-induced Vascular Injury: Current Status and Blueprint for the Future

enthalten in: Toxicologic pathology | 2014

von Mikaelian, I. | Cameron, M. | Dalmas, D. | +11

8

The Role of eNOS Phosphorylation in Causing Drug-induced Vascular Injury

enthalten in: Toxicologic pathology | 2014

von Tobin, G. | Zhang, J. | Goodwin, D. | +9

9

Establishing the Carcinogenic Risk of Immunomodulatory Drugs

enthalten in: Toxicologic pathology | 2012

von Weaver, J.

10

Establishing the carcinogenic risk of immunomodulatory drugs

enthalten in: Toxicologic pathology | 2012

von Weaver, J.